These differences explain why the same inflammatory trigger ultimately acts upon distinct, disease-specific key targets—such as Plin4 in male infertility, the MLL1/RBM15 epigenetic axis in pre-eclampsia, and FZD7 in ovarian cancer—leading to divergent pathological outcomes. This evidence concerns the gene FZD7 and ovarian cancer.